Elron Electronic moves to sell Elbit

Article

Elbit Medical Imaging parent Elron Electronic Industries announced Feb. 25 that it will sell its 37.3% stake in Elbit to Europe Israel for approximately $145 million. Haifa, Israel-based Elron Electronic is a high-tech holding company involved in defense

Elbit Medical Imaging parent Elron Electronic Industries announced Feb. 25 that it will sell its 37.3% stake in Elbit to Europe Israel for approximately $145 million. Haifa, Israel-based Elron Electronic is a high-tech holding company involved in defense electronics, communication, semiconductors, networking, software, and information technology. Europe Israel operates in three main areas: hotels, shopping and entertainment centers, and high-tech ventures. The deal is expected to close at the end of this month.

Elron’s effort to sell Elbit comes while Elbit is in negotiations with its subsidiary Elscint for the purchase of Elscint’s remaining shares. In February, Elbit offered Elscint about $100 million (SCAN 3/3/99) for the shares. An independent committee of outside directors formed by Elscint’s board issued a statement March 2 expressing willingness to begin negotiations for the deal.

As it contemplates its own sale, Elbit, also of Haifa, this month announced that it has been served with notice of a second shareholder lawsuit, similar to one filed late last year (SCAN 11/25/98). The second class-action suit is based on a comparable claim filed in November in the name of all holders of Elbit stock warrants since 1994. It claims that since Elbit did not disclose that it was planning to sell the bulk of Elscint’s business before the warrants expired, the plaintiffs were prevented from benefiting from the stock increase that resulted from the sale announcements.

The second suit requests damages for claimants who sold warrants between Aug. 1 and and Aug. 31, 1998 for a lower price than they would have received if Elbit had made its sale negotiations for Elscint known. Elbit rejects the claim and will attempt to have it dropped.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.